SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-17-059610
Filing Date
2017-11-07
Accepted
2017-11-07 16:39:03
Documents
2
Period of Report
2017-11-03

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2235
2 POA DOCUMENT poa.txt EX-24.3_750890 3106
  Complete submission text file 0001209191-17-059610.txt   6914
Mailing Address 6320 QUADRANGLE DRIVE SUITE 360 CHAPEL HILL NC 27517-8149
Business Address 6320 QUADRANGLE DRIVE SUITE 360 CHAPEL HILL NC 27517-8149 919-576-2306
MELINTA THERAPEUTICS, INC. /NEW/ (Issuer) CIK: 0001461993 (see all company filings)

IRS No.: 262644445 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL A8 H7L 4A8
Business Address
Wechsler Daniel Mark (Reporting) CIK: 0001582285 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35405 | Film No.: 171183904